Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2022 / Label-free quantification of RNA methylations using targeted mass spectrometry

Label-free quantification of RNA methylations using targeted mass spectrometry

04/05/2022

Share

 

Epitranscriptomics - the study of RNA modifications - is an emerging and promising research field. RNA modifications are involved in all steps of post-transcriptional regulation of gene expression (RNA structure, splicing, export; stability, cellular localization and translation). Finally, theses modifications are essential for key cellular functions such as survival, growth and differentiation.

Here we describe an experimental workflow for the quantification of methylated nucleosides from cellular mRNA based on separation and detection on a LCMS-8060 system.

 

 

In total, more than 170 RNA modifications - including RNA methylation - have been described. These modifications are present observed on all common RNA types (mRNA, tRNA, rRNA and, ncRNA).

The most common and abundant modifications on RNA in eukaryotes is N6-methyladenosine (m6A). m6A is important for mRNA regulation in physiological condition. As such, any dysregulation of m6A level may lead to disease [1]. This modification is not limited to mRNA but is also observed in other RNA species (rRNA, tRNA, snRNA).

 

 

Common technologies to detect m6A modifications [2] use next-generation sequencing techniques . However, these approaches cannot permit multiplex analysis of RNA methylations from a single sample. In addition, they do note enable precise quantification of individual chemical mark.

Mass spectrometry coupled to liquid chromatography has become a method of choice for accurately quantifying modified nucleosides from a biological sample. Here we present an application for the measurement of 14 distinct methylated nucleoside species using LC-MS/MS (Shimadzu LCMS-8060).

 

 

>> Download Application Note as a PDF ​​​​​​​

 

 

Find out more on Shimadzu's Website here. 

 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

HIVE scRNAseq Solution: A Case Study Demonstrating Sample Stability & Fragile Cell Recovery

January 4, 2022

Rapid Immunohistochemistry, Multiplex IF and Digital Pathology Workflow

January 4, 2022

Reduce Your Biomarker Optimization Time Burden with the LabSat® Research

January 31, 2022

Label-free quantification of RNA methylations using targeted mass spectrometry

April 5, 2022

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.